PubRank

Lorenz Meinel

Author PubWeight™ 37.79‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Silk microspheres for encapsulation and controlled release. J Control Release 2006 1.81
2 Growth factor gradients via microsphere delivery in biopolymer scaffolds for osteochondral tissue engineering. J Control Release 2008 1.72
3 Porous silk fibroin 3-D scaffolds for delivery of bone morphogenetic protein-2 in vitro and in vivo. J Biomed Mater Res A 2006 1.68
4 Bone morphogenetic protein-2 decorated silk fibroin films induce osteogenic differentiation of human bone marrow stromal cells. J Biomed Mater Res A 2004 1.59
5 Control of in vitro tissue-engineered bone-like structures using human mesenchymal stem cells and porous silk scaffolds. Biomaterials 2006 1.56
6 Cartilage-like tissue engineering using silk scaffolds and mesenchymal stem cells. Tissue Eng 2006 1.45
7 Silk fibroin as a vehicle for drug delivery applications. J Control Release 2010 1.40
8 Silk fibroin spheres as a platform for controlled drug delivery. J Control Release 2008 1.35
9 Localized delivery of growth factors for bone repair. Eur J Pharm Biopharm 2004 1.30
10 Effect of scaffold design on bone morphology in vitro. Tissue Eng 2006 1.28
11 Nondestructive micro-computed tomography for biological imaging and quantification of scaffold-bone interaction in vivo. Biomaterials 2007 1.24
12 Silk fibroin matrices for the controlled release of nerve growth factor (NGF). Biomaterials 2007 1.17
13 Insulin-like growth factor I releasing silk fibroin scaffolds induce chondrogenic differentiation of human mesenchymal stem cells. J Control Release 2007 1.12
14 Silk coatings on PLGA and alginate microspheres for protein delivery. Biomaterials 2007 1.06
15 Optimization strategies for electrospun silk fibroin tissue engineering scaffolds. Biomaterials 2009 1.03
16 Effects of chondrogenic and osteogenic regulatory factors on composite constructs grown using human mesenchymal stem cells, silk scaffolds and bioreactors. J R Soc Interface 2008 1.01
17 Microporous silk fibroin scaffolds embedding PLGA microparticles for controlled growth factor delivery in tissue engineering. Biomaterials 2009 0.98
18 Silk fibroin/hyaluronan scaffolds for human mesenchymal stem cell culture in tissue engineering. Biomaterials 2009 0.95
19 Electrospun matrices for localized drug delivery: current technologies and selected biomedical applications. Eur J Pharm Biopharm 2012 0.94
20 Non-invasive time-lapsed monitoring and quantification of engineered bone-like tissue. Ann Biomed Eng 2007 0.91
21 The support of adenosine release from adenosine kinase deficient ES cells by silk substrates. Biomaterials 2006 0.90
22 Biophysical properties of chitosan/siRNA polyplexes: profiling the polymer/siRNA interactions and bioactivity. J Control Release 2011 0.90
23 The use of sulfonated silk fibroin derivatives to control binding, delivery and potency of FGF-2 in tissue regeneration. Biomaterials 2009 0.88
24 Biopolymer-based growth factor delivery for tissue repair: from natural concepts to engineered systems. Tissue Eng Part B Rev 2009 0.87
25 Remodeling of tissue-engineered bone structures in vivo. Eur J Pharm Biopharm 2013 0.87
26 Bone targeting for the treatment of osteoporosis. J Control Release 2011 0.84
27 IGF-I and GH stimulate Phex mRNA expression in lungs and bones and 1,25-dihydroxyvitamin D(3) production in hypophysectomized rats. Eur J Endocrinol 2002 0.82
28 Insulin-like growth factor I-releasing alginate-tricalciumphosphate composites for bone regeneration. Pharm Res 2005 0.81
29 Design and validation of a novel bioreactor principle to combine online micro-computed tomography monitoring and mechanical loading in bone tissue engineering. Rev Sci Instrum 2010 0.79
30 In situ guided tissue regeneration in musculoskeletal diseases and aging : Implementing pathology into tailored tissue engineering strategies. Cell Tissue Res 2011 0.78
31 Biocompatibility and osteoconduction of macroporous silk fibroin implants in cortical defects in sheep. Eur J Pharm Biopharm 2013 0.78
32 An experimental animal model of aseptic loosening of hip prostheses in sheep to study early biochemical changes at the interface membrane. BMC Musculoskelet Disord 2004 0.78
33 Synthesis and structure-activity relationships of new quinolone-type molecules against Trypanosoma brucei. J Med Chem 2012 0.78
34 Ionic liquid versus prodrug strategy to address formulation challenges. Pharm Res 2014 0.78
35 Impact of IGF-I release kinetics on bone healing: a preliminary study in sheep. Eur J Pharm Biopharm 2013 0.77
36 The effect of hyaluronic acid on silk fibroin conformation. Biomaterials 2007 0.77
37 Foreword - In honor of Prof. em. Dr. Hans Peter Merkle on the occasion of his 70th birthday. Eur J Pharm Biopharm 2013 0.75
38 Site-Directed Immobilization of BMP-2: Two Approaches for the Production of Innovative Osteoinductive Scaffolds. Biomacromolecules 2017 0.75
39 Controlled protein delivery from electrospun non-wovens: novel combination of protein crystals and a biodegradable release matrix. Mol Pharm 2014 0.75
40 Insulin-like growth factor-I aerosol formulations for pulmonary delivery. Eur J Pharm Biopharm 2013 0.75
41 A perfluoroaromatic abiotic analog of H2 relaxin enabled by rapid flow-based peptide synthesis. Org Biomol Chem 2016 0.75
42 Development of silk fibroin-based beads for immobilized cell fermentations. J Microencapsul 2010 0.75